BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 9731006)

  • 1. Effects of theophylline on tolerance to the bronchoprotective actions of salmeterol in asthmatics in vivo.
    Cheung D; Wever AM; de GOEIJ JA; de GRAAFF CS; Steen H; Sterk PJ
    Am J Respir Crit Care Med; 1998 Sep; 158(3):792-6. PubMed ID: 9731006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
    Yates DH; Worsdell M; Barnes PJ
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
    Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
    N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
    Yates DH; Kharitonov SA; Barnes PJ
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
    Kalra S; Swystun VA; Bhagat R; Cockcroft DW
    Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ; Winter TH; Aalbers R
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma.
    Taylor DA; Jensen MW; Aikman SL; Harris JG; Barnes PJ; O'Connor BJ
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1731-7. PubMed ID: 9412548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance to the bronchoprotective effect of salmeterol 12 hours after starting twice daily treatment.
    Drotar DE; Davis EE; Cockcroft DW
    Ann Allergy Asthma Immunol; 1998 Jan; 80(1):31-4. PubMed ID: 9475563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids.
    Woolcock A; Lundback B; Ringdal N; Jacques LA
    Am J Respir Crit Care Med; 1996 May; 153(5):1481-8. PubMed ID: 8630590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salmeterol prevents aspirin-induced attacks of asthma and interferes with eicosanoid metabolism.
    Szczeklik A; Dworski R; Mastalerz L; Prokop A; Sheller JR; Nizankowska E; Cmiel A; Oates JA
    Am J Respir Crit Care Med; 1998 Oct; 158(4):1168-72. PubMed ID: 9769277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salmeterol versus theophylline in the treatment of asthma.
    Pollard SJ; Spector SL; Yancey SW; Cox FM; Emmett A
    Ann Allergy Asthma Immunol; 1997 May; 78(5):457-64. PubMed ID: 9164358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term circadian effects of salmeterol in asthmatic children treated with inhaled corticosteroids.
    Meijer GG; Postma DS; Mulder PG; van Aalderen WM
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1887-92. PubMed ID: 8520751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol.
    Lipworth BJ; Aziz I
    J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):88-92. PubMed ID: 9893190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
    Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
    Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance to the protective effects of salmeterol on methacholine-induced bronchoconstriction: influence of inhaled corticosteroids.
    Boulet LP; Cartier A; Milot J; Côté J; Malo JL; Laviolette M
    Eur Respir J; 1998 May; 11(5):1091-7. PubMed ID: 9648961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid onset of tolerance to the bronchoprotective effect of salmeterol.
    Bhagat R; Kalra S; Swystun VA; Cockcroft DW
    Chest; 1995 Nov; 108(5):1235-9. PubMed ID: 7587422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
    de Jong JW; van der Mark TW; Koëter GH; Postma DS
    Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma.
    Wiegand L; Mende CN; Zaidel G; Zwillich CW; Petrocella VJ; Yancey SW; Rickard KA
    Chest; 1999 Jun; 115(6):1525-32. PubMed ID: 10378544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.